Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palisade Bio (PALI) Operating Margin (2016 - 2023)

Palisade Bio has reported Operating Margin over the past 11 years, most recently at 1011.6% for Q1 2023.

  • Quarterly Operating Margin changed N/A to 1011.6% in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 5228.0% through Dec 2023, changed N/A year-over-year, with the annual reading at 5228.0% for FY2023, N/A changed from the prior year.
  • Operating Margin was 1011.6% for Q1 2023 at Palisade Bio, up from 129800.0% in the prior quarter.
  • Over five years, Operating Margin peaked at 1011.6% in Q1 2023 and troughed at 129800.0% in Q4 2020.
  • The 3-year median for Operating Margin is 73640.0% (2020), against an average of 66998.9%.
  • The largest YoY upside for Operating Margin was 6519841bps in 2020 against a maximum downside of -4933824bps in 2020.
  • A 3-year view of Operating Margin shows it stood at 85302.92% in 2019, then plummeted by -52bps to 129800.0% in 2020, then soared by 99bps to 1011.6% in 2023.
  • Per Business Quant, the three most recent readings for PALI's Operating Margin are 1011.6% (Q1 2023), 129800.0% (Q4 2020), and 72640.0% (Q3 2020).